1. Home
  2. WINT

WINT

Windtree Therapeutics Inc.

Logo Windtree Therapeutics Inc.

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

as 04-19-2024 2:32pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Windtree Therapeutics Inc is a development-stage biotechnology company focused on developing KL4 surfactant therapies for respiratory diseases. Its technology platform includes synthetic, peptide-containing surfactant and novel drug-delivery technologies that deliver aerosolized KL4 surfactants without invasive procedures. Its development program utilizing its proprietary technology platform is AEROSURF which is being developed for the treatment of respiratory distress syndrome in premature infants. It operates in the business segment of research and development of products focused on surfactant therapies for respiratory disorders and diseases, and the manufacture and commercial sales of approved products.

Founded: N/A Country:
United States
United States
Employees: N/A City: WARRINGTON
Market Cap: 4.0M IPO Year: 1995
Target Price: $1.00 AVG Volume (30 days): 172.7K
Analyst Decision: Hold Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -5.24 EPS Growth: N/A
52 Week Low/High: $0.28 - $18.48 Next Earning Date: 04-17-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: